Anti-TNF therapy use in pregnant patients with Crohn's disease and ulcerative colitis

被引：0
|
作者：
Kiely, C. [1 ]
Subramaniam, K. [1 ]
Pavli, P. [1 ]
机构：
[1] Canberra Hosp, Gastroenterol & Hepatol Unit, Garran, ACT, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [21] Safe and effective: anti-tumour necrosis factor therapy use in pregnant patients with Crohn disease and ulcerative colitis
    Kiely, C. J.
    Subramaniam, K.
    Platten, J.
    Pavli, P.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (05) : 616 - 619
  • [22] Adverse events related to the use of corticosteroids, immunosuppressants, and anti-TNFα therapy in Crohn's disease patients
    Sandborn, W.
    Arrighi, M.
    Hass, S.
    Clark, S.
    Tian, H.
    Marehbian, J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S493 - S494
  • [23] Anti-TNF therapy reduces ionising radiation exposure in patients with ulcerative colitis
    Aggarwal, D.
    Limdi, J. K.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S302 - S302
  • [24] Influence of Anti-TNF alpha Therapy on postoperative Morbidity in Patients with Ulcerative Colitis
    Groene, J.
    COLOPROCTOLOGY, 2018, 40 (05) : 375 - 376
  • [25] ANTI-TNF THERAPY REDUCES IONISING RADIATION EXPOSURE IN PATIENTS WITH ULCERATIVE COLITIS
    Aggarwal, D.
    Limdi, J. K.
    GUT, 2014, 63 : A156 - A156
  • [26] Ulcerative colitis and anti-TNFα (PDV)
    Nancey, S.
    Moussata, D.
    Flourie, B.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2007, 31 (01): : 84 - 87
  • [27] Biological Therapy for Ulcerative Colitis: What is after Anti-TNF
    Fiorino, Gionata
    Cesarini, Monica
    Danese, Silvio
    CURRENT DRUG TARGETS, 2011, 12 (10) : 1433 - 1439
  • [28] Effect of anti-TNFα therapy with daily physical activity in patients with Crohn's disease
    Lucca, F. A.
    Malaguti, C.
    Cabalzar, A. L.
    Chebli, L. A.
    Ribeiro, T. C. R.
    Gaburri, P. D.
    Chebli, J. M. F.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S344 - S344
  • [29] The role of pharmacogenomics in the prediction of efficacy of anti-TNF therapy in patients with Crohn's disease
    Mascheretti, S
    Schreiber, S
    PHARMACOGENOMICS, 2004, 5 (05) : 479 - 486
  • [30] Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
    Franco Leal, Raquel
    Planell, Nuria
    Kajekar, Radhika
    Lozano, Juan J.
    Ordas, Ingrid
    Dotti, Isabella
    Esteller, Miriam
    Carme Masamunt, M.
    Parmar, Harsukh
    Ricart, Elena
    Panes, Julian
    Salas, Azucena
    GUT, 2015, 64 (02) : 233 - 242
12345